Related Experiment Videos

Phenylethylaminergic mechanisms in attention-deficit disorder

G B Baker1, R A Bornstein, A C Rouget

  • 1PMHAC Research Unit, University of Alberta, Edmonton, Canada.

Biological Psychiatry
|January 1, 1991
PubMed

Insights

Attention-deficit hyperactivity disorder (ADHD) is linked to lower levels of key brain chemicals. This study found reduced urinary beta-phenylethylamine (PEA) and plasma phenylalanine (Phe) and p-tyrosine (Tyr) in children with ADHD.

Area of Science:

  • Neurochemistry
  • Pediatric Medicine
  • Biochemical Analysis

Background:

  • Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder.
  • Biochemical alterations may play a role in ADHD pathophysiology.
  • Specific neurotransmitter metabolites are implicated in brain function.

Purpose of the Study:

  • To investigate differences in specific biochemical markers between children with ADHD and healthy controls.
  • To quantify urinary and plasma levels of beta-phenylethylamine (PEA), phenylacetic acid (PAA), phenylalanine (Phe), and p-tyrosine (Tyr).

Main Methods:

  • Collected 24-hour urine samples and plasma from 18 normal children and 26 children diagnosed with ADHD.
  • Measured urinary excretion of PEA, PAA, Phe, and Tyr (per gram of creatinine).
  • Assessed plasma levels of PAA, Phe, and Tyr.

Main Results:

  • Urinary excretion of free and total PEA was significantly lower in children with ADHD.
  • Plasma levels of phenylalanine (Phe) and p-tyrosine (Tyr) were decreased in ADHD subjects compared to controls.
  • No significant difference was found in urinary phenylacetic acid (PAA) excretion.

Conclusions:

  • Reduced levels of PEA, Phe, and Tyr may be associated with ADHD.
  • These findings suggest potential neurochemical differences in ADHD.
  • Further research is warranted to explore the therapeutic implications of these biochemical markers.

Related Concept Videos